Author: Bella Hayes
IRVING, Texas, Jan. 07, 2025 (GLOBE NEWSWIRE) — Exela Technologies (OTC:), Inc. (Exela or the Company) (OTC: XELA, XELAP), a global business process automation leader, informs its stockholders and the market in general that today its Board of Directors approved the commencement of the process to: (i) voluntarily delist its securities from the Stock Market LLC (Nasdaq); and (ii) deregister the Company’s securities under the U.S. Securities Exchange Act of 1934, as amended (the Exchange Act), after taking into account a number of considerations, including, but not limited to, the Nasdaq Suspension (as defined below) and the expected reduction in…
Toronto, Ontario–(Newsfile Corp. – January 7, 2025) – Bluesky Digital Assets Corp., (CSE: BTC) (OTCQB: BTCWF) (“Bluesky” or the “Corporation”) announced today that it had closed and that it had secured a unsecured revolving credit facility (the “Facility”) from a group of three private lenders (the ‘Syndicate”) for the combined amount of $750,000 . The Facility bears a cash interest rate of 8% per annum. The Facility can be drawn upon in multiple advances. Any funds drawn upon will be used for general working capital purposes while the company advances its research and development and of it AI endeavours and…
U.Today – The trading volume of , the second-largest cryptocurrency by market capitalization, has significantly increased recently. This significant rise is a sign of increased market activity since it implies that traders and investors are participating more actively. Even though the price of ETH has recently dropped, there are indications that it might be ready for a comeback and even another rally. Ethereum, which is currently trading at about $3,632, just crossed its 50-day exponential moving average (EMA), a crucial resistance level that, when broken, frequently serves as a bullish indicator. The asset’s bullish structure on the daily chart has…
PASADENA, Calif.—Hamilton James C, Chief of Discovery/Trans Medicine at Arrowhead Pharmaceuticals, Inc. (NASDAQ:), a biotechnology company currently valued at $2.45 billion, sold a significant portion of his holdings in the company, according to a recent SEC filing. The transaction comes as the stock has declined over 50% in the past year, with InvestingPro data showing the company maintains strong liquidity with a current ratio of 6.74. The transactions, which took place on January 6, involved the sale of 32,729 shares of common stock, generating proceeds of $648,824. The shares were sold at prices ranging from $19.68 to $20.11, as part…
Monica L. Greenberg, Executive Vice President, Policy & General Counsel at LivePerson Inc. (NASDAQ:), recently sold 12,904 shares of the company’s common stock. The transaction, which took place on January 6, was executed at a price of $1.58 per share, amounting to a total value of $20,388. Following this sale, Greenberg retains direct ownership of 568,703 shares, a figure that includes 441,891 unvested restricted stock units. The shares were sold automatically by LivePerson to cover tax liabilities related to the vesting of restricted stock units. According to InvestingPro analysis, the company faces challenges with significant debt burden and rapid cash…
Combining AUO’s Display HMI and Himax’s Most Comprehensive Automotive IC Technologies to Shape the Future of Smart, Sustainable In-Car Displays TAINAN, Taiwan, Jan. 07, 2025 (GLOBE NEWSWIRE) — Himax Technologies (NASDAQ:), Inc. (Himax or Company) (: HIMX), an industry leader in fabless display driver ICs and semiconductors, and AUO Corporation (AUO) (TWSE: 2409), a technology-driven company advancing the frontier of display innovation, today announced their collaboration to showcase AUO’s groundbreaking Display HMI”AmLED ® integrated automotive display platform, featuring Himax’s advanced automotive IC solutions at CES 2025. Together, AUO and Himax form an intelligent automotive display platform that sets new benchmarks…
MENLO PARK, CA—Joshua M. Eizen, the Chief Operating Officer and Chief Legal Officer of AN2 Therapeutics, Inc. (NASDAQ:ANTX), recently sold 9,663 shares of the company’s common stock. The transaction, which took place on January 3, 2025, was valued at approximately $12,958, with the shares sold at an average price of $1.341 each. The sale was conducted to satisfy tax withholding obligations arising from the vesting of Restricted Stock Units (RSUs) on January 1, 2025. Following this transaction, Eizen retains ownership of 116,672 shares, which includes various RSUs scheduled to vest over the coming years, subject to his continued service with…
SAN JOSE, CA—Marc Nash, the Senior Vice President of Operations and R&D at Outset Medical (TASE:), Inc. (NASDAQ:OM), has sold 720 shares of the company’s common stock, according to a recent SEC filing. The transaction, conducted on January 7, 2025, was valued at approximately $928, with shares sold at a price of $1.29 each. Following this transaction, Nash retains ownership of 237,302 shares in the company. According to the filing, the shares were sold to cover tax withholding obligations related to previously earned performance stock units, and the sale does not represent a discretionary trade by Nash. InvestingPro analysis reveals…
SAN DIEGO–(BUSINESS WIRE)–California American Water (NYSE:), is here to help you ring in the new year with reminders and resolutions for saving water and money. Reminders “ Simplify this new year by signing up for MyWater, the fast and easy way to access and manage your water and/or wastewater account. If you are already enrolled, make sure your contact information is up to date. From the comfort of your home, you can:View and pay your billCheck your account balanceEnroll in Auto Pay and Paperless BillingSchedule service appointmentsSign up for customer assistanceTrack your water useTurn your service on or offReceive emergency…
Sean A. Power, the Chief Financial Officer of TG Therapeutics, Inc. (NASDAQ:), recently executed a series of stock sales amounting to $629,382, according to a recent SEC filing. The transactions, which took place on January 3 and January 6, involved the sale of 11,337 and 10,021 shares of common stock, respectively. The shares were sold at prices ranging from $28.534 to $30.294 per share. According to InvestingPro data, TGTX currently trades near $28, with analyst price targets ranging from $10 to $55, reflecting the stock’s notable volatility. These sales were conducted automatically to cover tax obligations related to the vesting…